Predictors of response to second-line endocrine therapy for breast cancer

Author： Cheung K.L.   Willsher P.C.   Pinder S.E.   Ellis I.O.   Elston C.W.   Nicholson R.I.   Blamey R.W.   Robertson a.J.F.R.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.45, Iss.3, 1997-09, pp. : 219-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treosulfan as an Effective Second-Line Therapy in Ovarian Cancer

By Gropp M.   Meier W.   Hepp H.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 94-98

Elsevier

Access to resources Recommend Favorite

Vinorelbine as first-line or second-line therapy for advanced breast cancer: A Phase I-II trial by the Danish Breast Cancer Co-operative Group

By Langkjer Sven   Ejlertsen Bent   Mouridsen Henning   Andersen Jørn   Møller Nielsen Mette   Åge Møller Knud   Lindegaard Madsen Ebbe   Haarh Vera  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 735-739

Informa Healthcare

Access to resources Recommend Favorite

Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial

By Brufsky Adam  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1067-1075

Springer Publishing Company

Access to resources Recommend Favorite

Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer

By Zielinski Christoph C.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 33-36

Springer Publishing Company

Access to resources Recommend Favorite

Challenges in defining predictive markers for response to endocrine therapy in breast cancer

By Larionov Alexey A   Miller William R  

Future Oncology, Vol. 5, Iss. 9, 2009-11 ,pp. : 1415-1428

Future Medicine

Access to resources Recommend Favorite